Multiresistant pathogens in cystic fibrosis

[1] AH TF, 2001, TRENDS MICROBIOL, V9, P34

[2] Multiple antibiotic resistance in Stenotrophomonas maltophilia [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1140 - 1142

[3] Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa [J]. MICROBIOLOGY-SGM, 1999, 145 : 2857 - 2862

[4] Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) : 39 - 45

[5] BALLESTERO S, 1993, INT CONGR SER, V1034, P55

[6] The treatment of respiratory pseudomonas infection in cystic fibrosis - What drug and which way? [J]. DRUGS, 2000, 60 (05) : 1053 - 1064

[7] BAXTER IA, 1994, FEMS MICROBIOL LETT, V122, P251, DOI 10.1016/0378-1097(94)00331-9

[8] Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015

[9] Blondeau J M, 2000, Semin Respir Infect, V15, P195

[10] Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) : 213 - 217

[1] AH TF, 2001, TRENDS MICROBIOL, V9, P34

[2] Multiple antibiotic resistance in Stenotrophomonas maltophilia [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1140 - 1142

[3] Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa [J]. MICROBIOLOGY-SGM, 1999, 145 : 2857 - 2862

[4] Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patients [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (01) : 39 - 45

[5] BALLESTERO S, 1993, INT CONGR SER, V1034, P55

[6] The treatment of respiratory pseudomonas infection in cystic fibrosis - What drug and which way? [J]. DRUGS, 2000, 60 (05) : 1053 - 1064

[7] BAXTER IA, 1994, FEMS MICROBIOL LETT, V122, P251, DOI 10.1016/0378-1097(94)00331-9

[8] Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015

[9] Blondeau J M, 2000, Semin Respir Infect, V15, P195

[10] Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) : 213 - 217